Literature DB >> 15629698

Loss-of-function mutation in tryptophan hydroxylase-2 identified in unipolar major depression.

Xiaodong Zhang1, Raul R Gainetdinov, Jean-Martin Beaulieu, Tatyana D Sotnikova, Lauranell H Burch, Redford B Williams, David A Schwartz, K Ranga R Krishnan, Marc G Caron.   

Abstract

Dysregulation of central serotonin neurotransmission has been widely suspected as an important contributor to major depression. Here, we identify a (G1463A) single nucleotide polymorphism (SNP) in the rate-limiting enzyme of neuronal serotonin synthesis, human tryptophan hydroxylase-2 (hTPH2). The functional SNP in hTPH2 replaces the highly conserved Arg441 with His, which results in approximately 80% loss of function in serotonin production when hTPH2 is expressed in PC12 cells. Strikingly, SNP analysis in a cohort of 87 patients with unipolar major depression revealed that nine patients carried the mutant (1463A) allele, while among 219 controls, three subjects carried this mutation. In addition, this functional SNP was not found in a cohort of 60 bipolar disorder patients. Identification of a loss-of-function mutation in hTPH2 suggests that defect in brain serotonin synthesis may represent an important risk factor for unipolar major depression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15629698     DOI: 10.1016/j.neuron.2004.12.014

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  123 in total

1.  What is a functional genetic polymorphism? Defining classes of functionality.

Authors:  Paul R Albert
Journal:  J Psychiatry Neurosci       Date:  2011-11       Impact factor: 6.186

Review 2.  Proteomic investigation of epigenetics in neuropsychiatric disorders: a missing link between genetics and behavior?

Authors:  Mariana D Plazas-Mayorca; Kent E Vrana
Journal:  J Proteome Res       Date:  2010-09-09       Impact factor: 4.466

3.  Translating progress in depression research to the clinic: one step at a time on a very long road.

Authors:  Wayne C Drevets
Journal:  World Psychiatry       Date:  2010-10       Impact factor: 49.548

Review 4.  Pharmacogenetics of antidepressant response.

Authors:  Stefano Porcelli; Antonio Drago; Chiara Fabbri; Sara Gibiino; Raffaella Calati; Alessandro Serretti
Journal:  J Psychiatry Neurosci       Date:  2011-03       Impact factor: 6.186

5.  Genetic dissociation of acquisition and memory strength in the heat-box spatial learning paradigm in Drosophila.

Authors:  Soeren Diegelmann; Melissa Zars; Troy Zars
Journal:  Learn Mem       Date:  2006-01-17       Impact factor: 2.460

6.  Postmortem parietal cortex TPH2 expression is not altered in schizophrenic, unipolar-depressed, and bipolar patients vs control subjects.

Authors:  Alon Shamir; Galit Shaltiel; Itzhak Levi; R H Belmaker; Galila Agam
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

7.  Pathophysiology of depression: do we have any solid evidence of interest to clinicians?

Authors:  Gregor Hasler
Journal:  World Psychiatry       Date:  2010-10       Impact factor: 49.548

Review 8.  Translational research in central nervous system drug discovery.

Authors:  Orest Hurko; John L Ryan
Journal:  NeuroRx       Date:  2005-10

9.  Resequencing of serotonin-related genes and association of tagging SNPs to citalopram response.

Authors:  Eric J Peters; Susan L Slager; Greg D Jenkins; Megan S Reinalda; Holly A Garriock; Stanley I Shyn; Jeffrey B Kraft; Patrick J McGrath; Steven P Hamilton
Journal:  Pharmacogenet Genomics       Date:  2009-01       Impact factor: 2.089

10.  Associations between central nervous system serotonin, fasting glucose, and hostility in African American females.

Authors:  Stephen H Boyle; Anastasia Georgiades; Beverly H Brummett; John C Barefoot; Ilene C Siegler; Wayne R Matson; Cynthia M Kuhn; Katherine Grichnik; Mark Stafford-Smith; Redford B Williams; Rima Kaddurah-Daouk; Richard S Surwit
Journal:  Ann Behav Med       Date:  2015-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.